Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells

scientific article published on January 2007

Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TRANSPROCEED.2006.11.004
P932PMC publication ID1859859
P698PubMed publication ID17275522
P5875ResearchGate publication ID6528271

P50authorJohn Julian FungQ61476062
P2093author name stringL Lu
C-L Chen
S Qian
R Tao
L-T Huang
M-M Tiao
C-D Liang
P2860cites workContribution of direct and indirect recognition pathways to T cell alloreactivityQ36361819
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factorQ36365242
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigensQ36400803
A role for transforming growth factor-beta in the veto mechanism in transplant toleranceQ36746903
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activityQ45281233
The role of T-cell costimulatory activation pathways in transplant rejectionQ47955940
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.Q52965072
Prolongation of cardiac allograft survival with transforming growth factor-beta 1 in ratsQ72112702
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survivalQ74015557
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)281-282
P577publication date2007-01-01
P1433published inTransplantation ProceedingsQ7834825
P1476titleCross-tolerance of recipient-derived transforming growth factor-beta dendritic cells
P478volume39

Reverse relations

Q93079047Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapycites workP2860

Search more.